1.
Savvidou Α, Constantinidou A, Zacharia L, Michailidou K, Zanti Μ, Kitiri S, et al. Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer. World J Oncol [Internet]. 2026 Jan. 1 [cited 2026 May 9];17(3):380-93. Available from: https://wjon.elmerpub.com/wjon/article/view/2750